| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |